RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Bachem Holding Stock

Bachem Holding Net Income 2024

Bachem Holding Net Income

118.39 M CHF

Ticker

BANB.SW

ISIN

CH0012530207

WKN

914589

In 2024, Bachem Holding's profit amounted to 118.39 M CHF, a 5.84% increase from the 111.86 M CHF profit recorded in the previous year.

The Bachem Holding Net Income history

YEARNET INCOME (undefined CHF)
2029e333.3
2028e307.54
2027e257.55
2026e192.98
2025e148.27
2024e118.39
2023111.86
2022100.68
2021114.68
202078.06
201954.16
201846.64
201741.77
201641.21
201531.84
201429.07
201323.6
201215.56
20119.41
201028.3
200946.06
200858.71
200763.93
200646.65
200539.38
200430.71

Bachem Holding Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Bachem Holding, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Bachem Holding from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Bachem Holding’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Bachem Holding. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Bachem Holding’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Bachem Holding’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Bachem Holding’s growth potential.

Bachem Holding Revenue, EBIT and net profit per share

DateBachem Holding RevenueBachem Holding EBITBachem Holding Net Income
2029e1.59 B undefined0 undefined333.3 M undefined
2028e1.35 B undefined325.09 M undefined307.54 M undefined
2027e1.15 B undefined262.92 M undefined257.55 M undefined
2026e1.01 B undefined224.98 M undefined192.98 M undefined
2025e790.08 M undefined169.01 M undefined148.27 M undefined
2024e628.18 M undefined128.2 M undefined118.39 M undefined
2023577.32 M undefined129.38 M undefined111.86 M undefined
2022531.74 M undefined127.22 M undefined100.68 M undefined
2021503.23 M undefined128.93 M undefined114.68 M undefined
2020402 M undefined96.66 M undefined78.06 M undefined
2019313.72 M undefined62.36 M undefined54.16 M undefined
2018282.5 M undefined54.81 M undefined46.64 M undefined
2017261.61 M undefined50.61 M undefined41.77 M undefined
2016236.48 M undefined45.06 M undefined41.21 M undefined
2015208.6 M undefined38.5 M undefined31.84 M undefined
2014183.94 M undefined35.86 M undefined29.07 M undefined
2013170.69 M undefined29.45 M undefined23.6 M undefined
2012157.3 M undefined22.33 M undefined15.56 M undefined
2011145.81 M undefined14.86 M undefined9.41 M undefined
2010152.88 M undefined15.68 M undefined28.3 M undefined
2009181.85 M undefined50.88 M undefined46.06 M undefined
2008195 M undefined69.68 M undefined58.71 M undefined
2007198.32 M undefined72.44 M undefined63.93 M undefined
2006171.75 M undefined55.75 M undefined46.65 M undefined
2005153.77 M undefined47.16 M undefined39.38 M undefined
2004147.86 M undefined41.47 M undefined30.71 M undefined

Bachem Holding stock margins

The Bachem Holding margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Bachem Holding. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Bachem Holding.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Bachem Holding's sales revenue. A higher gross margin percentage indicates that the Bachem Holding retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Bachem Holding's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Bachem Holding's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Bachem Holding's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Bachem Holding. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Bachem Holding's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Bachem Holding Margin History

Bachem Holding Gross marginBachem Holding Profit marginBachem Holding EBIT marginBachem Holding Profit margin
2029e30.65 %0 %20.91 %
2028e30.65 %24.01 %22.71 %
2027e30.65 %22.8 %22.34 %
2026e30.65 %22.23 %19.07 %
2025e30.65 %21.39 %18.77 %
2024e30.65 %20.41 %18.85 %
202330.65 %22.41 %19.38 %
202232.21 %23.93 %18.93 %
202133.13 %25.62 %22.79 %
202032.07 %24.05 %19.42 %
201929.48 %19.88 %17.27 %
201829.46 %19.4 %16.51 %
201731.62 %19.35 %15.97 %
201632.67 %19.05 %17.42 %
201533.79 %18.45 %15.26 %
201434.36 %19.5 %15.8 %
201334.95 %17.25 %13.83 %
201232.45 %14.2 %9.89 %
201129.59 %10.19 %6.45 %
201034.36 %10.25 %18.51 %
200949.87 %27.98 %25.33 %
200854.94 %35.73 %30.11 %
200755.37 %36.53 %32.23 %
200653.11 %32.46 %27.16 %
200586.76 %30.67 %25.61 %
200485.42 %28.05 %20.77 %

Bachem Holding Aktienanalyse

What does Bachem Holding do?

The Bachem Holding AG is a leading provider of peptides and biochemical agents for the pharmaceutical and biotechnological industry. The company was founded in 1971 in Bubendorf, Switzerland, and has been listed on the Swiss stock exchange since 1998. The company's history began with the founding of Bachem Chemie GmbH by Peter Grogg, a former chemical engineer at Ciba-Geigy. Grogg started the company with a focus on peptide synthesis, an area that was still in its infancy at the time. Over time, Bachem expanded its core business by entering into other areas such as peptide formulation, plant extract manufacturing, and nucleotide synthesis. Today, the company has around 1,400 employees worldwide and operates production and research facilities in Europe, North America, and Asia. Bachem is considered one of the largest peptide manufacturers globally and supplies customers in over 100 countries. The business model of Bachem Holding AG is heavily focused on research and development (R&D). The company invests approximately 15% of its revenue annually in R&D to maintain and expand its leading position in peptide chemistry and biochemical agents. These investments have allowed Bachem to offer a wide range of products and services that meet various customer requirements. The company operates several business segments, including peptides and biochemicals, pharmaceutical contract manufacturing and GMP manufacturing, generic drugs, research services, and products for the diagnostics market. The peptides and biochemicals segment is the core of the company and includes a wide range of peptides, amino acids, peptide libraries, peptide-drug conjugates, synthetic proteins, and bioactive peptides. Bachem also manufactures synthetic peptide kits and customized peptides for research and development. The company is also active in pharmaceutical contract manufacturing, offering customized manufacturing services for bioactive peptides, synthetic drugs, oligonucleotides, and drug-drug conjugates. Customers can benefit from synthesis development to commercial production of active substances. Bachem has also positioned itself in the generic drug market, offering a wide range of peptide-based generics such as buserelin, leuprorelin, and triptorelin. The generic drugs segment was expanded in 2015 through the acquisition of the American biotechnology company American Peptide Company. In addition to manufacturing peptides and biochemical agents, Bachem also provides research services, including peptide synthesis, peptide conjugation with drugs, analysis of protein-protein interactions, and identification of peptide libraries. The company is also active in the diagnostics market, offering a wide range of peptides and antibodies for use in diagnostic products for research and clinical applications. In summary, the Bachem Holding AG is a leading provider of peptides and biochemical agents for the pharmaceutical and biotechnological industry. The company heavily invests in research and development and offers a wide range of products and services to meet various customer requirements. Bachem Holding ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Bachem Holding's Profit Margins

The profit margins of Bachem Holding represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Bachem Holding's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Bachem Holding's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Bachem Holding's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Bachem Holding’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Bachem Holding stock

How much profit has Bachem Holding made this year?

Bachem Holding has made 118.39 M CHF this year.

How has the profit developed compared to last year?

The profit has increased by 5.84% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Bachem Holding publish its earnings?

Bachem Holding publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Bachem Holding?

The profits of Bachem Holding are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Bachem Holding?

You can learn more about the earnings of Bachem Holding by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Bachem Holding pay?

Over the past 12 months, Bachem Holding paid a dividend of 0.37 CHF . This corresponds to a dividend yield of about 0.49 %. For the coming 12 months, Bachem Holding is expected to pay a dividend of 0.39 CHF.

What is the dividend yield of Bachem Holding?

The current dividend yield of Bachem Holding is 0.49 %.

When does Bachem Holding pay dividends?

Bachem Holding pays a quarterly dividend. This is distributed in the months of May, May, May, May.

How secure is the dividend of Bachem Holding?

Bachem Holding paid dividends every year for the past 26 years.

What is the dividend of Bachem Holding?

For the upcoming 12 months, dividends amounting to 0.39 CHF are expected. This corresponds to a dividend yield of 0.52 %.

In which sector is Bachem Holding located?

Bachem Holding is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bachem Holding kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bachem Holding from 4/30/2024 amounting to 0.4 CHF, you needed to have the stock in your portfolio before the ex-date on 4/26/2024.

When did Bachem Holding pay the last dividend?

The last dividend was paid out on 4/30/2024.

What was the dividend of Bachem Holding in the year 2023?

In the year 2023, Bachem Holding distributed 0.35 CHF as dividends.

In which currency does Bachem Holding pay out the dividend?

The dividends of Bachem Holding are distributed in CHF.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Bachem Holding

Our stock analysis for Bachem Holding Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bachem Holding Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.